AVEO Pharmaceuticals, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 4
- DOL-certified
- 100%
- Median offered wage
- $145,000
Boston, MA NAICS: 5417
AVEO Pharmaceuticals, Inc.'s H-1B LCA filing count
U.S. Department of Labor's OFLC discloses 4 Labor Condition Application filings naming AVEO Pharmaceuticals, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
USCIS adjudication record for AVEO Pharmaceuticals, Inc.
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 14 H-1B petitions naming AVEO Pharmaceuticals, Inc. through FY2023, and approved the large majority of them: 92.9% approved (13 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
AVEO Pharmaceuticals, Inc. is listed in 4 DOL LCA filings, more filings than 73% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $145,000. This is not a USCIS approval, hiring, or sponsorship ranking.
- 4
- DOL LCA filings, FY2023–FY2026
- 100%
- DOL-certified
- $145,000
- median offered wage
- Top 27%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Boston, MA.
AVEO Pharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
4 40444th of 122824 higher than 82,380 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · AVEO Pharmaceuticals, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $130,000–$160,000 .
Title concentration
- Senior Analyst, Commercial Analytics 2 · 50% · $130,000
- PV Specialist, Compliance and Alliance Manager 2 · 50% · $160,000
Worksite counties
- CHESTER, PA 2 · 100%
Thin filer, multi-state worksites
Only 4 LCAs, but worksites already span 2 states (MA, PA). HQ Boston, MA · DOL cert 100%.
Geographic Distribution
Where AVEO Pharmaceuticals, Inc. places H-1B workers across the United States
Recent LCA Filings
Latest H-1B labor condition applications filed by AVEO Pharmaceuticals, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| PV Specialist, Compliance and Alliance Manager | Boston, MA | $160,000 | Certified | FY2026 |
| PV Specialist, Compliance and Alliance Manager | Boston, MA | $160,000 | Certified | FY2026 |
| Senior Analyst, Commercial Analytics | DOWNINGTOWN, PA | $130,000 | Certified - Withdrawn | FY2025 |
| Senior Analyst, Commercial Analytics | DOWNINGTOWN, PA | $130,000 | Certified | FY2023 |
Nationwide peers near AVEO Pharmaceuticals, Inc.'s 4-LCA band
Cross-state DOL neighbors for AVEO Pharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($145,000 here).
Disclaimer: Informational only, not professional advice.
Read with AVEO Pharmaceuticals, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs AVEO Pharmaceuticals, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs AVEO Pharmaceuticals, Inc.); CERT-LOCK · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs AVEO Pharmaceuticals, Inc.); CERT-SOFT · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 4 LCAs (Δ 0 heavier vs AVEO Pharmaceuticals, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from AVEO Pharmaceuticals, Inc.'s TRACE-BOOK.
Open the MA state board after the ABS peers. AVEO Pharmaceuticals, Inc. stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
AVEO Pharmaceuticals, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for AVEO Pharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- AVEO Pharmaceuticals, Inc. filed 4 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 73% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.